Thank you. Your answer is in.
Your next step
The AOM Practice Brief by Glivara Clinical
A pharmacist-led briefing for owners and leaders of obesity-medicine practices: the obesity-medication developments that matter, and what they may mean for clinical care, medication access, and clinic workflow.
- New drugs, indications, formulations, and meaningful safety developments
- Coverage, cash pricing, manufacturer programs, shortages, and access
- Important trials, guidelines, and regulatory changes
- Implications for initiation, titration, switching, monitoring, and follow-up
- What practice owners should watch, verify, or prepare for
Monthly, plus occasional urgent updates when something major changes. First issue coming soon.